Article
A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation.
Oncology (Williston Park, N.Y.) - 10 Jun 2024
Trinh Jonathan Q, Banskota Shristi Upadhyay, Marr Alissa S
Abstract excerpt
Spiradenocarcinomas are rare malignant skin adnexal tumors. We describe a novel case of a patient with an aggressive CDKN2A-mutated spiradenocarcinoma who responded to a CDK4/6 inhibitor. This case highlights the unique nature of spiradenocarcinomas as well as the potential benefit of targeted therapy.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
